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Abstract
Background: Improved dementia identification is a global health priority, and general practitioners (GPs) are often
the first point of contact for people with concerns about their cognition. However, GPs often express uncertainty in
using assessment tools and the evidence based on which tests are most accurate in identifying dementia is unclear. In
particular, there is little certainty around how the accuracy of available brief cognitive assessments compares within a
clinical family practice setting.
Grounded in existing brief cognitive assessment evidence, we will compare the diagnostic test accuracy of the Mini
Mental State Examination (MMSE) to the General Practitioner Assessment of Cognition (GPCOG) against the best
available reference standard when used within a family practice setting.
Methods: We will employ robust systematic review methods to assess studies of diagnostic accuracy where both the
MMSE and GPCOG have been evaluated as direct comparisons, i.e. within the same study population. This approach will
enable us to minimise between-study heterogeneity, to eliminate the risk of bias due to confounding and increase the
opportunity to make clinically useful and useable comparisons of diagnostic accuracy across both the MMSE and
GPCOG. This systematic review will be conducted using a pragmatic search strategy, refining searches that build upon
studies identified as part of our overview of systematic reviews of the diagnostic accuracy of brief cognitive assessments
for identifying dementia in primary care.
Discussion: Through this systematic review, we aim to improve existing evidence on how the diagnostic accuracy of
MMSE and GPCOG compares when used to identify dementia within the family practice setting. We also aim to make
clinical practice recommendations based upon the variations in diagnostic accuracy identified between the MMSE and
GPCOG.
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Background
Improved dementia diagnosis is a global health priority
of international bodies such as the World Health
Organization [1] and the G8 [2]. Existing delays in the
diagnostic pathway have led to debates around case find-
ing and targeted screening within primary care [3–6].
General practitioners (GPs) are often the first point of
contact for people with concerns about their cognition,
yet GPs often express uncertainty in using assessment
tools alongside concerns around the consequences of
misdiagnosing dementia [5, 7, 8]. In established health-
care systems, guidelines on the most accurate brief cog-
nitive assessment for identifying dementia in primary
care are inconsistent and variable in their specific rec-
ommendations. Whilst there is variation in guidance on
thresholds, accuracy and suitability of test within dif-
ferent populations, guidelines often feature the same
subset of brief cognitive assessments. Examples are avail-
able in the UK from the National Institute for Health
and Care Excellence [9] and the Royal College of Psychi-
atrists [10], and in the Netherlands from the Huisartsen
Genootschap (GP Society) [11]. These all include the
Mini Mental State Examination (MMSE) and the Gen-
eral Practitioner Assessment of Cognition (GPCOG).
A number of systematic reviews [12–18] have explored
the individual diagnostic accuracy of brief cognitive as-
sessments for dementia in isolation, and across a range
of populations and settings. In an overview of systematic
reviews of the diagnostic accuracy of brief cognitive as-
sessments for identifying dementia in primary care, we
identified two brief cognitive assessments that can be
compared to identify the test with better diagnostic per-
formance. These tests were two of the three most fre-
quently assessed brief cognitive assessments within the
13 included systematic reviews [12, 13, 19–29] with the
MMSE featuring in 8 reviews and the GPCOG featuring
in 4 reviews. The clock drawing test (CDT) was the third
most frequently assessed tool, featuring in 4 reviews. We
judged this to be less comparable to the MMSE in terms
of administration complexity, timing and domains
assessed, compared to the GPCOG. As the most fre-
quently assessed test within our overview, the MMSE is
also included as one of the index tests within this review
as, whilst copyright restrictions are now enforced, it re-
mains one of the most popular brief cognitive assess-
ments employed in practice [27, 30]. The MMSE is
based on a 30-point scale of 11 questions testing five do-
mains of cognitive function (orientation, registration, at-
tention and calculation, recall and language) [31]. The
GPCOG was the second most frequently assessed index
test within our overview. The GPCOG is a publicly
available test that has two sections: a patient examin-
ation (GPCOG-patient) with a maximum score of 9
(optimum performance) covering time orientation, clock
drawing, reporting recent events and a word-recall task,
and an optional informant questionnaire (GPCOG-in-
formant) with a maximum score of 6 with questions asses-
sing the patient’s memory of recent events and their
executive function [32]. In comparison, the CDT is a
standard assessment where the patient is asked to draw a
clock face marking the hours and then draw the hour and
minute hands to correctly indicate a specific time (e.g.
quarter past 3). There are a number of scoring ap-
proaches, but the Shulman method uses a 6-point scoring
system [33] whilst the Sunderland method uses a 10-point
system [34]. Taking into consideration the ubiquity of the
index tests, the comparability of the tests mentioned
above and their common use within guidelines, we have
chosen to compare the MMSE against the GPCOG as
index tests within this systematic review. Therefore, the
aim of this systematic review is to compare the diagnostic
accuracy evidence of the MMSE and the GPCOG for
identifying dementia, particularly within a primary care
setting and using direct (within study) comparisons.
This use of direct comparisons should reduce
between-study heterogeneity and allow us to draw firm
conclusions about the comparative accuracy of these
brief cognitive assessments within the same or similar
populations [35, 36]. To our knowledge, this type of sys-
tematic review has not previously been conducted to
compare the accuracy of brief cognitive assessments for
identifying dementia.
This evidence will contribute strongly to clinical prac-
tice and policy making by demonstrating the presence or
absence of superiority in the diagnostic accuracy of
GPCOG relative to that of MMSE for identifying de-
mentia in primary care.
Methods
The primary outcome is the comparative accuracy of the
two tests assessed via direct comparisons, i.e. the diag-
nostic accuracy of the two tests are compared within the
same population in a study (comparative study).
The secondary outcome of the review is to identify
other common test-related factors identified by included
studies, such as ease of administration or administration
time. Whilst beyond our primary focus of test accuracy,
these other factors may contribute to the overall useful-
ness of the tests when applied in a primary care setting,
and we will incorporate them in our findings in order to
make useful research and clinical recommendations.
This systematic review will be conducted using a prag-
matic search strategy, refining searches that build upon
studies identified as part of our overview of systematic
reviews of the diagnostic accuracy of brief cognitive
assessments for identifying dementia in primary care.
Further details are given below (PROSPERO reference
42015022078).
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Overview search methods
To build the search database for the overview of system-
atic reviews of the diagnostic accuracy of brief cognitive
assessments for identifying dementia in primary care, we
searched the Cochrane Database of Systematic Reviews,
EMBASE, MEDLINE and PsychINFO for systematic re-
views from inception until August 2015. Search strat-
egies are shown in the Additional file 1. According to
best searching practice for diagnostic accuracy reviews,
we applied no date or language restrictions, and where
reviews were updated, we used the latest version avail-
able. Additional papers were identified through Zetoc
alerts and incorporated at the title and abstract screen-
ing phase. We ran updated searches on the Cochrane
Database of Systematic Reviews in February 2016.
Eligibility criteria
Adults aged 18 years or over recruited from a primary
care or general practice population were included, and we
did not exclude patients who were selected on the basis of
an existing diagnosis or condition which might reasonably
be expected to feature in primary care (e.g. stroke).
The target condition was all-cause (non-differentiated)
dementia. We also included reviews that focused spe-
cifically on differentiated forms of dementia such as
Alzheimer’s disease, vascular dementia and dementia
with Lewy bodies. We excluded reviews that focused on
mild cognitive impairment (MCI). Where reviews investi-
gated both dementia and MCI, we extracted data referring
to dementia and excluded data referring solely to MCI.
Identification of studies for this systematic review
To identify eligible studies for this systematic review, we
will first assess the 13 systematic reviews included within
our overview review (methods described above) and
identify included reviews that contained studies includ-
ing direct comparisons of the diagnostic accuracy of
MMSE and GPCOG for identifying dementia in primary
care. Once we have identified these studies, we will carry
out citation tracking via Google Scholar, i.e. clicking on
the appropriate link (e.g. “cited by 15”) to view details
on the articles that have cited the original study. We will
also use these initial studies to conduct snowball search-
ing, i.e. checking the bibliographies for relevant original
studies for possible inclusion within this systematic re-
view. We will use Zetoc alerts to proactively identify
recent studies published that meet our criteria (using
the terms “MMSE”, “GPCOG”, “test accuracy” and “de-
mentia”). Finally, when we have identified studies using
the above methods, we will conduct a traditional search
taking a start date 1 year prior to the most recently pub-
lished identified study up to the current day, using
MEDLINE, EMBASE and PsychINFO databases. The ra-
tionale is that this search will cover the maximum period
of time not covered in the overview review searches with
some date overlap to ensure all potential sources are in-
cluded, using the most efficient means to identify the
most recent evidence. This will also enable us to confirm
whether we identified all relevant studies via the over-
view searches.
Index tests
The index tests are the MMSE [31] and the GPCOG
[32]. The MMSE is one of the most widely used brief
cognitive assessments currently used, and development
of the GPCOG has been independent to the develop-
ment of the MMSE.
The conventional threshold for the MMSE is 24 (also
shown as <24), where out of a maximum possible 30
points, scores below 24 indicate impairment [22]. The
GPCOG comprises of two sections: the section com-
pleted by the individual being assessed, known as
GPCOG-patient, and an optional section for a relative
or friend to complete (if present) known as GPCOG-
informant. GPCOG-patient has 9 items with possible
total scores of between 0 (indicating severe impairment)
and 9 (indicating no impairment). GPCOG-informant
has 6 items with possible total scores of between 0 (indi-
cating severe impairment) and 6 (indicating no impair-
ment). GPCOG-patient can be conducted by itself, with
a conventional threshold of 8 out of 9 (<8). If informants
are available, a score of GPCOG-patient between 5 and
8 precipitates the GPCOG-informant and the scores are
combined (“GPCOG-total”) with a conventional thresh-
old of 11 out of a maximum 15 (<11). If no informant is
available, the conventional threshold of 8 stands. It is
also possible to conduct a staged GPCOG assessment
where GPCOG-informant is only required if GPCOG-
patient is scored between 5 and 8 out of 9. This is
known as “GPCOG Two stage”.
For our assessment, we will stratify GPCOG into 3 types
of test: GPCOG-patient with a threshold of <8, GPCOG-
total with a threshold of <11 and GPCOG Two stage [37].
Reference standard
There is currently no gold standard test for identifying
dementia in primary care. We will accept reference stan-
dards consisting of the following tools alone, clinical
diagnosis alone or clinical diagnosis combined with one
or a combination of the following assessment tools:
– Diagnostic and Statistical Manual (DSM) III/III-R/
IV/IV-R,
– Clinical Dementia Rating (CDR),
– International Classification of Diseases (ICD) 10,
– Geriatric Mental State–Automated Geriatric
Examination for Computer Assisted Taxonomy
(GMS-AGECAT),
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– Cambridge Mental Disorders of the Elderly
Examination (CAMDEX),
– International Psychogeriatric Association World
Health Organization (IPA-WHO) criteria.
Reference standards are selected on the basis of many
variables such as common practice within individual
clinics, practitioner preference, specialisation and experi-
ence of healthcare professionals and practice managers
and are subject to changes in cost and fashion. Many of
the globally accepted reference standards such as the
World Health Organization-supported ICD and the
DSM produced by the American Psychiatric Association
are updated regularly; the DSM-5 (sometimes referred to
as DSM-V) was released in 2013 [38], and the ICD-11 is
due for release by 2018 [39].
Data extraction, selection and coding
All sources will be managed using the latest version of
EndNote software. Two reviewers will pilot the screen-
ing for titles and abstracts on the first 15 sources, and
we will write screening notes to help with title/abstract
and full-text screening. Title/abstract and full-text
screening will be conducted by the same two reviewers,
and a third reviewer will resolve any disagreements.
A bespoke data abstraction form will be piloted by two
reviewers using two included studies. Key data extracted
will include characteristics of included systematic re-
views (references and author details, overall goal of re-
view, date review conducted, date published, participant
details), included study details (such as authors, year of
study, date of publication, country of study, outcomes
reported, test timings) and general review limitations as
well as components of the 2 × 2 table (TP, FP, TN, FN)
or other accuracy data such as sensitivity, specificity and
disease prevalence if raw numbers are not available. The
data abstraction form will be accompanied by a briefing
document explaining how it should be used. Data will be
abstracted by one reviewer, spot-checked by a second,
with a third reviewer acting as moderator if necessary.
Assessment of methodological quality
We will use the QUADAS-2 [40] tool to assess meth-
odological quality of diagnostic accuracy studies for sys-
tematic reviews. Whilst this tool is developed for studies
focussing on a single index test, we will assess the suit-
ability of using the tool for studies that focus on direct
comparisons of two index tests by piloting the
QUADAS-2 tool on one of the included studies. We will
tailor QUADAS-2 in line with suitability in assessing
quality of studies using direct comparisons, for example
assessing the reference standard against MMSE and then
the reference standard against GPCOG.
Data synthesis and analysis
Study of specific estimates of the sensitivity and specifi-
city (and their 95% confidence intervals) of GPCOG and
MMSE will be presented graphically on a forest plot. We
will also use these forest plots and summary receiver op-
erating characteristic (SROC) plots to visually explore
heterogeneity.
We will consider possible sub-group analyses investigat-
ing, for example tests using lower and higher thresholds.
Other aspects that may be suitable for investigating
through sub-grouping could include variations in popula-
tion details such as prevalence, and variations in cases and
control groups (e.g. confirmed dementia, probably demen-
tia, people with memory problems, healthy people).
We will perform meta-analysis if the quantity and na-
ture of the included studies permit. Again, if data allow,
we will use a hierarchical meta-regression model with
test type as a covariate to estimate and compare SROC
curves or summary points [36]. A priori uncertainty
about thresholds for determining test positivity and the
likelihood of implicit thresholds suggests estimation of
SROC curves using a hierarchical SROC (HSROC)
meta-regression model may be preferable [41]. However,
we will consider using a bivariate meta-regression model
to estimate and compare summary points [42, 43] if
studies use a common threshold.
We will create a summary of result table with add-
itional summary tables of subgroup results (potential
subgroups listed above) if relevant. If feasible and appro-
priate, we will consider translating any summary results
into natural frequencies and other metrics such as pre-
dictive values to help improve understanding by readers.
We will not assess reporting bias because its impact
on diagnostic accuracy is unclear, and the tools for in-
vestigating it are in the early stages of development [44].
Discussion
We do not foresee any practical or operational issues
with the conduct of this systematic review. All differ-
ences between the protocol and systematic review will
be reported in the full systematic review.
Additional file
Additional file 1: Search strategy, formatted for EMBASE (OVID).
(DOCX 24 kb)
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